BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 15384018)

  • 1. Increased risk of mortality associated with hip fracture in the dialysis population.
    Mittalhenkle A; Gillen DL; Stehman-Breen CO
    Am J Kidney Dis; 2004 Oct; 44(4):672-9. PubMed ID: 15384018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis.
    Danese MD; Kim J; Doan QV; Dylan M; Griffiths R; Chertow GM
    Am J Kidney Dis; 2006 Jan; 47(1):149-56. PubMed ID: 16377396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total hip arthroplasty in chronic dialysis patients in the United States.
    Abbott KC; Bucci JR; Agodoa LY
    J Nephrol; 2003; 16(1):34-9. PubMed ID: 12649533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duration of end-stage renal disease and kidney transplant outcome.
    Goldfarb-Rumyantzev A; Hurdle JF; Scandling J; Wang Z; Baird B; Barenbaum L; Cheung AK
    Nephrol Dial Transplant; 2005 Jan; 20(1):167-75. PubMed ID: 15546892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fracture risk after parathyroidectomy among chronic hemodialysis patients.
    Rudser KD; de Boer IH; Dooley A; Young B; Kestenbaum B
    J Am Soc Nephrol; 2007 Aug; 18(8):2401-7. PubMed ID: 17634437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk-adjusted mortality rates of elderly veterans with hip fractures.
    Bass E; French DD; Bradham DD; Rubenstein LZ
    Ann Epidemiol; 2007 Jul; 17(7):514-9. PubMed ID: 17420142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: a meta-analysis.
    Heinz J; Kropf S; Luley C; Dierkes J
    Am J Kidney Dis; 2009 Sep; 54(3):478-89. PubMed ID: 19359080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of mortality in elderly patients with hip fractures: a two-year prospective study of 1,944 patients.
    Söderqvist A; Ekström W; Ponzer S; Pettersson H; Cederholm T; Dalén N; Hedström M; Tidermark J;
    Gerontology; 2009; 55(5):496-504. PubMed ID: 19628932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hip fractures in end-stage renal disease patients: incidence, risk factors, and prevention.
    Leinau L; Perazella MA
    Semin Dial; 2006; 19(1):75-9. PubMed ID: 16423185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mineral metabolism and cardiovascular morbidity and mortality risk: peritoneal dialysis patients compared with haemodialysis patients.
    Noordzij M; Korevaar JC; Bos WJ; Boeschoten EW; Dekker FW; Bossuyt PM; Krediet RT
    Nephrol Dial Transplant; 2006 Sep; 21(9):2513-20. PubMed ID: 16799173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone mineral density in end-stage renal disease patients: association with wasting, cardiovascular disease and mortality.
    Matsubara K; Suliman ME; Qureshi AR; Axelsson J; Martola L; Heimbürger O; Barany P; Stenvinkel P; Lindholm B
    Blood Purif; 2008; 26(3):284-90. PubMed ID: 18421213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombotic microangiopathy in United States long-term dialysis patients.
    Perkins RM; Reynolds JC; Ahuja TS; Reid T; Agodoa LY; Bohen EM; Yuan CM; Abbott KC
    Nephrol Dial Transplant; 2006 Jan; 21(1):191-6. PubMed ID: 16204286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD.
    Honda H; Qureshi AR; Heimbürger O; Barany P; Wang K; Pecoits-Filho R; Stenvinkel P; Lindholm B
    Am J Kidney Dis; 2006 Jan; 47(1):139-48. PubMed ID: 16377395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association of lipid levels with mortality in patients on chronic peritoneal dialysis.
    Habib AN; Baird BC; Leypoldt JK; Cheung AK; Goldfarb-Rumyantzev AS
    Nephrol Dial Transplant; 2006 Oct; 21(10):2881-92. PubMed ID: 16735386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjusted mortality after hip fracture: From the cardiovascular health study.
    Robbins JA; Biggs ML; Cauley J
    J Am Geriatr Soc; 2006 Dec; 54(12):1885-91. PubMed ID: 17198494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of erythrocyte blood transfusions on survival after surgery for hip fracture.
    Engoren M; Mitchell E; Perring P; Sferra J
    J Trauma; 2008 Dec; 65(6):1411-5. PubMed ID: 19077635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for pulmonary embolism in chronic dialysis patients.
    Tveit DP; Hshieh P; Cruess D; Agodoa LY; Welch PG; Abbott KC
    J Nephrol; 2002; 15(3):241-7. PubMed ID: 12113594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic kidney disease and risk of incident myocardial infarction and all-cause and cardiovascular disease mortality in middle-aged men and women from the general population.
    Meisinger C; Döring A; Löwel H;
    Eur Heart J; 2006 May; 27(10):1245-50. PubMed ID: 16611670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dementia as a predictor of mortality in dialysis patients.
    Rakowski DA; Caillard S; Agodoa LY; Abbott KC
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):1000-5. PubMed ID: 17699319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excess mortality due to interaction between protein-energy wasting, inflammation and cardiovascular disease in chronic dialysis patients.
    de Mutsert R; Grootendorst DC; Axelsson J; Boeschoten EW; Krediet RT; Dekker FW;
    Nephrol Dial Transplant; 2008 Sep; 23(9):2957-64. PubMed ID: 18400817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.